Bafna Pharmaceuticals P/B Ratio
Bafna Pharmaceuticals P/B ratio. Bafna Pharmaceuticals (BAFNAPH) P/B ratio is 16.47 (High), book value per share ₹255.00 vs Healthcare average P/B of 0.01 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see BAFNAPH share price.
Current Valuation Metrics
Book Value Breakdown (2020)
Valuation Signal
Sector Context
BAFNAPH P/B Ratio — Valuation Insights & Book Value Analysis
Bafna Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 16.47 (High). Analyse BAFNAPH promoter holding to track promoter, FII and institutional holdings.
- Stock appears overvalued with PB of 16.47, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 2358.2% above historical average
- Trading at premium to sector average PB of 0.01
Bafna Pharmaceuticals P/B Ratio Historical Trend
BAFNAPH annual price-to-book ratio — 1 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Bafna Pharmaceuticals yearly highs lows for the annual high/low range and current price position.
BAFNAPH Historical P/B Ratio — Book Value Per Share & Year-End Price
Bafna Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2020 | 0.67 | ₹255.0 | ₹170.85 | ₹51 | Low |
BAFNAPH vs Healthcare Peers — P/B Ratio Comparison
Bafna Pharmaceuticals P/B 16.47 vs Healthcare average 0.01, median 0.61 — range -6.55–1.13.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.19 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |